📊 1. Report: Point to Points
🔹 Product Launch Announcement:
Wanbury Limited has launched two innovative pharmaceutical products:
• Formulation (Branded Generic) – C-RED Hematinic Iron Tablets
• API (Bulk Drug) – Ketamine Hydrochloride
🔸 About C-RED Iron Tablets:
• Targets iron deficiency and anemia, especially in pregnant women
• Branded as a Liposomal Iron product – superior to conventional iron salts
• Key benefits: Better absorption, no gastric issues, rapid hemoglobin rise
🔸 Why it Matters:
• India faces >40% anemia prevalence among males and females
• Liposomal Iron ensures enhanced safety and tolerability
🔹 About Ketamine Hydrochloride (API):
• Developed through cost-effective, high-quality in-house R&D
• Meets USP & EP pharmacopeia standards
• Demand exceeds 200 tons annually for human & veterinary use
• Used as anesthetic agent in surgeries – hospital-grade injectable
• Wanbury to export Ketamine to European markets
🔸 Company Growth Strategy:
• Strengthen presence in gynecology & critical care segment
• Tap export opportunities for Ketamine – revenue boost
🔹 Past Brand Note:
Wanbury had a successful iron supplement, C Pink, divested during debt settlement – C-RED marks comeback in iron therapy market.
📈 2. Effect on Share Market
• Positive Investor Sentiment: Product launch signals growth focus, likely leading to short-term stock price increase.
• Export Revenue Potential: Entry into European markets for Ketamine to boost earnings – medium-term valuation uplift.
• Re-entry into Iron Supplement Segment: Could regain lost market share, enhancing domestic revenues.
• Strong R&D Capability Displayed: In-house development demonstrates technical strength, increasing investor confidence.
🏢 3. Company Overview – Wanbury Limited
• Established: 1988
• Stock Listings: NSE (WANBURY), BSE (524212)
• Global Presence: API exports to 50+ countries
• Facilities: USFDA & EUGMP approved at Tanuku (AP) & Patalganga (MH)
• API Portfolio: Metformin, Sertraline, Tramadol, Diphenhydramine, and more
• Formulation Segments: Gynaecology, Nutraceuticals, Gastrointestinal, Anti-inflammatory
🔗 Website: wanbury.com
📌 40%+ Indians Anemic – C-RED Targets This Gap
📌“With C-RED and Ketamine, Wanbury redefines its growth trajectory.”
📌“Track here for the Wanbury’s performance
📉 Stock Market Disclaimer
Disclaimer: This post is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy/sell any stock or share. Investing in the stock market involves risk. Past performance is not indicative of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.
